The role of tumor size, ultrasonographic findings, and serum tumor markers to predict the likelihood of malignant testicular histology

Gang Song; Gang Song; Yu Fan; Yu Fan; Gengyan Xiong; Gengyan Xiong; Guangjie Ji; Guangjie Ji; Cong Huang; Cong Huang; Yongming Kang; Yongming Kang; Jinchao Chen; Jinchao Chen; Da Ren; Da Ren; Qun He; Qun He; He Wang; He Wang; Gangzhi Shan; Gangzhi Shan; Shuqing Li; Shuqing Li; Zhisong He; Zhisong He; Liqun Zhou; Liqun Zhou

doi:10.18632/oncotarget.23802

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 12/27/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

The role of tumor size, ultrasonographic findings, and serum tumor markers to predict the likelihood of malignant testicular histology

Gang Song _, Gang Song, Yu Fan, Yu Fan, Gengyan Xiong, Gengyan Xiong, Guangjie Ji, Guangjie Ji, Cong Huang, Cong Huang, Yongming Kang, Yongming Kang, Jinchao Chen, Jinchao Chen, Da Ren, Da Ren, Qun He, Qun He, He Wang, He Wang, Gangzhi Shan, Gangzhi Shan, Shuqing Li, Shuqing Li, Zhisong He, Zhisong He, Liqun Zhou and Liqun Zhou _

Gang Song1,*, Yu Fan1,*, Gengyan Xiong1, Guangjie Ji1, Cong Huang1, Yongming Kang1,2, Jinchao Chen1, Da Ren1, Qun He1, He Wang1, Gangzhi Shan1, Shuqing Li1, Zhisong He1 and Liqun Zhou1

1 Department of Urology, Peking University First Hospital. Institute of Urology, Peking University. National Urological Cancer Center, Beijing, China

2. Department of Urology, Suining Central Hospital, Sichuan, China

* These authors have contributed equally

Correspondence:

Gengyan Xiong, email: [email protected]

Liqun Zhou, email: [email protected]

Keywords: testicular tumor; malignant likelihood; predictive model; urological oncology

Received: August 03, 2017 Accepted: November 19, 2017 Epub: December 27, 2017

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23802

Publication Alerts

Withdrawal Notice

Research Papers:

The role of tumor size, ultrasonographic findings, and serum tumor markers to predict the likelihood of malignant testicular histology